• KAFM
  • Contact us
  • E-Submission
ABOUT
ARTICLE CATEGORY
BROWSE ARTICLES
AUTHOR INFORMATION

Page Path

9
results for

"Glomerular Filtration Rate"

Filter

Article category

Keywords

Publication year

Authors

"Glomerular Filtration Rate"

Original Articles
Impact of Sleep Duration on Decline in Kidney Function in Adult Patients with Hypertension: A Community-Based Prospective Cohort Study
Yoon Jun Cha, Ju Young Kim, Eunbyul Cho, Keehyuck Lee, Kiheon Lee, Woo Kyung Bae, Hyejin Lee, Jong Soo Han, Se Young Jung, Sumi Lee
Korean J Fam Med 2022;43(5):312-318.   Published online September 20, 2022
DOI: https://doi.org/10.4082/kjfm.21.0164
Background
Sleep duration is associated with various health conditions, including chronic kidney disease. However, the association between sleep duration and decline in kidney function in the South Korean population remains unclear. We aimed to investigate the impact of sleep duration on kidney function decline in adult patients with hypertension.
Methods
This cohort study was performed using data obtained from the Korean Genome and Epidemiology Study; 2,837 patients with hypertension who initially had normal kidney function were included. Glomerular filtration rates (GFRs) were estimated at baseline and throughout the 16 years of follow-up. A person was considered to have a decline in kidney function if they had a GFR <60 mL/min/1.73 m2. Sleep duration data were obtained through interviewer-assisted questionnaires. Sleep durations were classified as short (<6 hours), normal (≥6 hours but <9 hours), and long (≥9 hours). The Cox proportional hazards model was applied, with adjustments for covariates.
Results
After adjusting for covariates, sleep duration was not associated with a decline in kidney function. However, among men with poorly controlled hypertension at baseline, compared to men with normal sleep durations, men with sleep durations <6 hours had a significantly higher risk of kidney function decline (hazard ratio, 1.56; 95% confidence interval, 1.02–2.36).
Conclusion
Short sleep duration did not seem to be associated with an increased risk of decline in kidney function; however, it may be a risk factor for the decline in kidney function in men with poorly controlled hypertension.

Citations

Citations to this article as recorded by  
  • The risk of chronic kidney disease or proteinuria with long or short sleep duration: a systematic review and meta-analysis of cohort studies
    Meng Hu, Yongchong Wang, Wen Zhu, Xiaozhen Chen
    Clinical and Experimental Nephrology.2025; 29(3): 301.     CrossRef
  • Short or long sleep duration was associated with chronic kidney disease in the general population
    Gang Wang, Ning Zhuo, Zhichun Liu
    International Urology and Nephrology.2024; 56(7): 2441.     CrossRef
  • The association of sleep duration with the risk of chronic kidney disease: a systematic review and meta-analysis
    Jin Hean Koh, Brian Sheng Yep Yeo, Timothy Wei En Tan, Mark Yong Siang See, Adele Chin Wei Ng, Shaun Ray Han Loh, Joshua Gooley, Chieh Suai Tan, Song Tar Toh
    Clinical Kidney Journal.2024;[Epub]     CrossRef
  • Association of plant and animal protein intake with sleep quality and quality of life in hemodialysis patients: a multicenter cross-sectional study
    Saber Jafari Maskouni, Hossein Bavi Behbahani, Meysam Alipour, Ahmad Zare Javid, Fatemeh Fayazfar, Pardis Tofighzadeh, Shiva Shokri, Sara Keramatzadeh, Haleh Soltaniyan Dehkordi, Morteza Sharifat, Siavash Babajafari Esfandabad, Shokouh Shayanpour
    Frontiers in Nutrition.2024;[Epub]     CrossRef
  • 4,121 View
  • 76 Download
  • 4 Web of Science
  • 4 Crossref
The Association between Obesity Phenotypes and Early Renal Function Decline in Adults without Hypertension, Dyslipidemia, and Diabetes
Jung In Choi, Young Hye Cho, Sang Yeoup Lee, Dong Wook Jeong, Jeong Gyu Lee, Yu Hyeon Yi, Young Jin Tak, Seung Hun Lee, Hye Rim Hwang, Eun Ju Park
Korean J Fam Med 2019;40(3):176-181.   Published online May 10, 2019
DOI: https://doi.org/10.4082/kjfm.18.0139
Background
The prevalence of chronic kidney disease is increasing worldwide. Several studies have suggested that obesity is associated with early renal dysfunction. However, little is known about the relationship between obesity phenotypes and early renal function decline. Therefore, this study aimed to identify the relationship between obesity phenotypes and early renal function decline in adults without hypertension, dyslipidemia, and diabetes.
Methods
We conducted a cross-sectional analysis of clinical and anthropometric data from 1,219 patients who underwent a routine health checkup in 2014. We excluded adults with cardiovascular disease, renal disease, diabetes, hypertension, dyslipidemia, or low glomerular filtration rate (<60 mL/min/1.73 m2). Renal function was determined according to the estimated glomerular filtration rate calculated using the Chronic Kidney Disease Epidemiology Collaboration creatinine-cystatin C equation.
Results
Age, sex, body mass index, waist circumference, triglyceride, low-density lipoprotein, and fasting glucose had an association with the estimated glomerular filtration rate. After adjusting for age, sex, smoking status, and alcohol intake, the odds ratios of the metabolically abnormal normal weight and metabolically abnormal obese phenotypes for the presence of low estimated glomerular filtration rates were 1.807 (95% confidence interval, 1.009– 3.236) and 1.834 (95% confidence interval, 1.162–2.895), compared with the metabolically healthy normal weight phenotype. However, the metabolically healthy obese phenotype did not show a significant association with early renal function decline.
Conclusion
In this cross-sectional study, we confirmed the association between the metabolically abnormal normal weight and metabolically abnormal obese phenotypes and early kidney function decline in adults without hypertension, dyslipidemia, and diabetes.

Citations

Citations to this article as recorded by  
  • Obesity as a Risk Factor for Hyperglycemia, Electrolyte Disturbances, and Acute Kidney Injury in the Emergency Department
    Iulia Najette Crintea, Alexandru Cristian Cindrea, Ovidiu Alexandru Mederle, Teodor Florin Fulga, Adina Maria Marza, Alina Petrica, Cosmin Iosif Trebuian, Romulus Timar
    Biomedicines.2025; 13(2): 349.     CrossRef
  • Obesity Class and Severity of Metabolic Emergencies: A Single-Center Retrospective Five-Year Study
    Iulia Najette Crintea, Alexandru Cristian Cindrea, Teodor Florin Fulga, Cosmin Iosif Trebuian, Adina Maria Marza, Alina Petrica, Ovidiu Alexandru Mederle, Romulus Timar
    Healthcare.2025; 13(6): 617.     CrossRef
  • Metabolically healthy obesity and chronic kidney disease risk: exploring the dynamics
    Mustafa GULDAN, Lasin OZBEK, Ahmet U. TOPCU, Adrian COVIC, Mehmet KANBAY
    Panminerva Medica.2024;[Epub]     CrossRef
  • Visceral Adiposity Index and Lipid Accumulation Product as Effective Markers of Different Obesity Phenotypes in Korean Adults: A Cross-Sectional Analysis
    Sung Ryul Yu, Kyung-A Shin
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 495.     CrossRef
  • Metabolically healthy obesity is associated with higher risk of both hyperfiltration and mildly reduced estimated glomerular filtration rate: the role of serum uric acid in a cross-sectional study
    Hong Zhang, Rui Chen, Xiaohong Xu, Minxing Yang, Wenrong Xu, Shoukui Xiang, Long Wang, Xiaohong Jiang, Fei Hua, Xiaolin Huang
    Journal of Translational Medicine.2023;[Epub]     CrossRef
  • Prevalence and associations of metabolic syndrome in patients with alcohol use disorder
    Anna Hernández-Rubio, Arantza Sanvisens, Ferran Bolao, Isabel Cachón-Suárez, Carme Garcia-Martín, Antoni Short, Ramón Bataller, Roberto Muga
    Scientific Reports.2022;[Epub]     CrossRef
  • Effects of bariatric surgery on renal function and associated factors with bivariate analysis: a cohort study
    Juliana Amaro Borborema Bezerra, Eduardo Pachu Raia dos Santos, Carlos Teixeira Brandt
    F1000Research.2022; 11: 409.     CrossRef
  • Metabolic obesity phenotypes and chronic kidney disease: a cross-sectional study from the RaNCD cohort study
    Samira Arbabi Jam, Behrooz Moloudpour, Farid Najafi, Mitra Darbandi, Yahya Pasdar
    BMC Nephrology.2022;[Epub]     CrossRef
  • Abdominal obesity phenotypes and risk of kidney function decline: Tehran Lipid and Glucose Study
    Asharf Shahali, Erfan Tasdighi, Maryam Barzin, Maryam Mahdavi, Majid Valizadeh, Mahtab Niroomand, Fereidoun Azizi, Farhad Hosseinpanah
    Obesity Research & Clinical Practice.2020; 14(2): 168.     CrossRef
  • Obese First degree relatives of hemodialysis patients are at Higher Risk for Developing Kidney Diseases: In a Cross-sectional Study
    Abozaid Mohammed Elemam
    Sudan Journal of Medical Sciences.2019; 14(3): 143.     CrossRef
  • 7,803 View
  • 125 Download
  • 9 Web of Science
  • 10 Crossref
Low Estimated Glomerular Filtration Rate Is Prevalent among North Korean Refugees in South Korea
Young-Soo Song, Seong-Woo Choi
Korean J Fam Med 2018;39(3):161-167.   Published online May 18, 2018
DOI: https://doi.org/10.4082/kjfm.2018.39.3.161
Background
The number of North Korean refugees entering South Korea is rising. Few studies have investigated the risk of non-communicable disease in North Korean refugees. Moreover, kidney insufficiency, a risk factor for cardiovascular disease, has not been studied in this population. We compared the prevalence of non-communicable disease and kidney function in North Korean refugees and South Koreans.
Methods
Our study was conducted using a case-control design. We enrolled 118 North Korean refugees from the Hana Center and selected 472 randomly sampled South Korean individuals as controls, who were age- and sex-matched with the North Korean refugees in a ratio of 1:4, from the 2014 Korea National Health and Nutrition Examination Survey database.
Results
The prevalence of non-communicable disease did not differ significantly between the groups; however, a low estimated glomerular filtration rate (eGFR; <90 mL/min per 1.73 m2) was more prevalent in the North Korean refugees than in the South Korean population (52.1% vs. 29.9%, P<0.001). After adjusting for covariates and weight gain after escape, the prevalence of a low eGFR was associated with the length of residence in South Korea (odds ratio, 2.84; 95% confidence interval, 1.02–7.89).
Conclusion
The prevalence of non-communicable disease did not differ between North Korean refugees and the South Korean population, while a low eGFR was more prevalent in North Korean refugees than in South Koreans. Moreover, after adjusting for other covariates, the prevalence of a low eGFR in North Korean refugees was associated with the length of residence in South Korea.

Citations

Citations to this article as recorded by  
  • Health and Integration of North Korean Refugees in South Korea
    Hye-Seung Wee, Daehwan Kim
    SSRN Electronic Journal.2023;[Epub]     CrossRef
  • Health and Labour Market Outcomes of North Korean Refugees in South Korea
    Hyeseung Wee, Daehwan Kim
    Global Economic Review.2023; 52(4): 251.     CrossRef
  • 6,086 View
  • 76 Download
  • 2 Web of Science
  • 2 Crossref
Effect of Fenofibrate Medication on Renal Function
Sungjong Kim, Kyungjin Ko, Sookyoung Park, Dong Ryul Lee, Jungun Lee
Korean J Fam Med 2017;38(4):192-198.   Published online July 20, 2017
DOI: https://doi.org/10.4082/kjfm.2017.38.4.192
Background

Fibrates are widely used to treat hypertriglyceridemia, a risk factor for arteriosclerosis, but these compounds have been associated with renal dysfunction. This study aimed to investigate the effects of fibrates on renal function in relatively healthy adult subjects with no cardiovascular diseases.

Methods

This retrospective study included 558 outpatients who were prescribed 160 mg fenofibrate (fenofibrate group) or 10 mg atorvastatin (control group) between August 2007 and October 2015. The groups were randomly matched using propensity scores at a 1:1 ratio. Serum creatinine levels and estimated glomerular filtration rates before and after treatment were compared between the two groups.

Results

Patients in the fenofibrate group showed greater changes in serum creatinine levels than those in the control group (9.73%±9.83% versus −0.89%±7.37%, P<0.001). Furthermore, 55.1% of patients in the fenofibrate group, but only 6.1% of those in the control group, exhibited a serum creatinine level increase ≥0.1 mg/dL (P<0.001). The fenofibrate group showed significantly greater declines in the estimated glomerular filtration rate than the control group (−10.1%±9.48% versus 1.42%±9.42%, P<0.001). Moreover, 34.7% of the fenofibrate group, but only 4.1% of the control group, exhibited an estimated glomerular filtration rate decrease ≥10 mL/min·1.73 m2 (P<0.001).

Conclusion

Fenofibrate treatment resulted in increased serum creatinine levels and reduced estimated glomerular filtration rates in a primary care setting. Therefore, regular renal function monitoring should be considered essential during fibrate administration.

Citations

Citations to this article as recorded by  
  • An interracial Mendelian analysis revealed a link between lipid‐lowering drugs and renal failure
    Naidan Zhang, Chaixia Ji, Baibing Xie, Yaoyang Liu, Chengliang Yuan
    Lipids.2025;[Epub]     CrossRef
  • Pemafibrate improves liver biochemistry and GLOBE scores in patients with primary biliary cholangitis: Nationwide, multicenter study by the Japanese Red Cross Liver Study Group
    Keiji Tsuji, Nobuharu Tamaki, Masayuki Kurosaki, Nami Mori, Shintaro Takaki, Kazuki Ohya, Toshie Mashiba, Hironori Ochi, Haruhiko Kobashi, Chikara Ogawa, Michiko Nonogi, Hideo Yoshida, Takehiro Akahane, Masahiko Kondo, Toyotaka Kasai, Hideki Fujii, Yasush
    Hepatology Research.2025; 55(5): 675.     CrossRef
  • Fenofibrate-Induced Osmotic Nephropathy: A Novel Mechanism of Acute Kidney Injury
    Raymond Lin, Seethalakshmi Viswanathan, Nikki L. Wong
    American Journal of Kidney Diseases.2025;[Epub]     CrossRef
  • Icariside II prevents kidney fibrosis development in chronic kidney disease by promoting fatty acid oxidation
    Meng Wang, Jing Wang, Lingchen Wang, Xiaoxuan Feng, Yiling Qian, Chaoyang Ye, Chen Wang
    Phytotherapy Research.2024; 38(2): 839.     CrossRef
  • Shen-Shuai-II-Recipe inhibits tubular inflammation by PPARα-mediated fatty acid oxidation to attenuate fibroblast activation in fibrotic kidneys
    Meng Wang, Lingchen Wang, Liang Zhou, Yizeng Xu, Chen Wang
    Phytomedicine.2024; 126: 155450.     CrossRef
  • Frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients: A retrospective cross-sectional study in a Malaysian primary care clinic
    Jazlan Jamaluddin, Mohamed-Syarif Mohamed-Yassin, Siti Nuradliah Jamil, Mohd Azzahi Mohamed Kamel, Mohamad Ya'akob Yusof
    Heliyon.2023; 9(4): e14998.     CrossRef
  • Saroglitazar is noninferior to fenofibrate in reducing triglyceride levels in hypertriglyceridemic patients in a randomized clinical trial
    Rene Rodriguez-Gutierrez, Jose Gerardo González, Deven Parmar, Farheen. Shaikh, Pio Cruz-López
    Journal of Lipid Research.2022; 63(7): 100233.     CrossRef
  • PPAR Alpha as a Metabolic Modulator of the Liver: Role in the Pathogenesis of Nonalcoholic Steatohepatitis (NASH)
    Simona Todisco, Anna Santarsiero, Paolo Convertini, Giulio De Stefano, Michele Gilio, Vito Iacobazzi, Vittoria Infantino
    Biology.2022; 11(5): 792.     CrossRef
  • Three-dimensional electrochemical degradation of p-aminophenol with efficient honeycomb block AC@Ti-Cu-Ni-Zn-Sb-Mn particle electrodes
    Jia Wan, Feiping Zhao, Yong Meng, Mengyan Guo, Chong-jian Tang, Yan Shi, Yong Ke, Rong Hu
    Separation and Purification Technology.2021; 267: 118662.     CrossRef
  • Updates on the Current Treatments for Diabetic Retinopathy and Possibility of Future Oral Therapy
    Yohei Tomita, Deokho Lee, Kazuo Tsubota, Kazuno Negishi, Toshihide Kurihara
    Journal of Clinical Medicine.2021; 10(20): 4666.     CrossRef
  • Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis
    Kazufumi Dohmen, Shin-ya Onohara, Shigeru Harada
    The Korean Journal of Gastroenterology.2021; 78(4): 227.     CrossRef
  • Drug Therapies Affecting Renal Function: An Overview
    Reem Y Alhassani, Reem M Bagadood, Rafal N Balubaid, Haneen I Barno, Mariah O Alahmadi, Nahla A Ayoub
    Cureus.2021;[Epub]     CrossRef
  • Defective Mitochondrial Fatty Acid Oxidation and Lipotoxicity in Kidney Diseases
    Hee-Seong Jang, Mi Ra Noh, Jinu Kim, Babu J. Padanilam
    Frontiers in Medicine.2020;[Epub]     CrossRef
  • Fenofibrate-induced renal dysfunction, yes or no?
    Fatemeh Emami, Amirali Hariri, Mohammad Matinfar, Mehdi Nematbakhsh
    Journal of Research in Medical Sciences.2020; 25(1): 39.     CrossRef
  • PPARα Agonist Oral Therapy in Diabetic Retinopathy
    Yohei Tomita, Deokho Lee, Kazuo Tsubota, Toshihide Kurihara
    Biomedicines.2020; 8(10): 433.     CrossRef
  • Dyslipidemia in patients with chronic kidney disease: etiology and management
    Magdaléna Dušejovská, Marek Vecka, Ivan Rychlík, Aleš Žák
    Vnitřní lékařství.2020; 66(5): 275.     CrossRef
  • Lipid-lowering and antioxidative effects ofApium graveolensL. root flavonoid extracts
    Yuan He, Yang Shi, Airong Zhang, Xiaoxia Zhang, Jing Sun, Li Tian
    RSC Advances.2019; 9(46): 26757.     CrossRef
  • Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence
    Hong Sheng Cheng, Wei Ren Tan, Zun Siong Low, Charlie Marvalim, Justin Yin Hao Lee, Nguan Soon Tan
    International Journal of Molecular Sciences.2019; 20(20): 5055.     CrossRef
  • 6,439 View
  • 84 Download
  • 19 Web of Science
  • 18 Crossref
Background

The glomerular filtration rate (GFR) decreases with age, while parathyroid hormone (PTH) increases. There are a few reports only on the relationship between GFR and PTH under the category of serum 25-hydroxyvitamin D (25[OH]D) concentration.

Methods

Using the Korea National Health and Nutrition Examination Survey (KNHANES) data, a cross-sectional study was conducted on the association between serum 25(OH)D concentration, GFR and PTH in Korean adults aged 50 years or older. Serum PTH concentration was compared to the tertiles of GFR after adjustment for relevant variables. In addition, the serum PTH concentration was compared with the GFR under the category of serum 25(OH) D concentration (<20, 20-30, >30 ng/mL).

Results

The mean estimated GFR (eGFR) was 74.8 mL/min in men and 73.1 mL/min in women. The mean PTH and 25(OH) D was 66.8 pg/mL, 20.5 ng/mL in men and 69.0 pg/mL, 18.2 ng/mL in women. The serum PTH concentration showed a significant negative correlation with the serum 25(OH) D and eGFR in both genders. The serum PTH concentration significantly increased at the lower tertile of eGFR in male adults In addition, a decrease of serum PTH concentration was marked in the vitamin D sufficient male adults (>30 ng/mL).

Conclusion

This present study demonstrated that serum PTH concentration showed negative correlation with eGFR, however, serum PTH increase may be minimized by maintaining proper serum 25(OH)D concentrations under similar eGFR status in Korean adults aged 50 and above.

Citations

Citations to this article as recorded by  
  • Race-specific associations of 25-hydroxyvitamin D and parathyroid hormone with cardiometabolic biomarkers among US white and black postmenopausal women
    Jin Xia, Wanzhu Tu, JoAnn E Manson, Hongmei Nan, Aladdin H Shadyab, Jennifer W Bea, Ting-Yuan D Cheng, Lifang Hou, Yiqing Song
    The American Journal of Clinical Nutrition.2020; 112(2): 257.     CrossRef
  • Gender specific association of parathyroid hormone and vitamin D with metabolic syndrome in population with preserved renal function
    Min-Hee Kim, Jeongmin Lee, Jeonghoon Ha, Kwanhoon Jo, Dong-Jun Lim, Jung-Min Lee, Sang-Ah Chang, Moo-Il Kang, Bong Yun Cha
    Scientific Reports.2018;[Epub]     CrossRef
  • Parathyroid Hormone Levels Are Independently Associated with eGFR and Albuminuria: The Dong-gu Study
    Seong-Woo CHOI, Sun-Seog KWEON, Young-Hoon LEE, So-Yeon RYU, Jin-Su CHOI, Hae-Sung NAM, Kyeong-Soo PARK, Sun A KIM, Min-Ho SHIN
    Journal of Nutritional Science and Vitaminology.2018; 64(1): 18.     CrossRef
  • Lifestyle and Dietary Factors Associated with Serum 25-Hydroxyvitamin D Levels in Korean Young Adults
    Hee-Kyung Joh, Chun Soo Lim, BeLong Cho
    Journal of Korean Medical Science.2015; 30(8): 1110.     CrossRef
  • 5,052 View
  • 29 Download
  • 6 Web of Science
  • 4 Crossref
Background

Recent studies suggest that coffee consumption has an influence on kidney function. This study investigated the relationship between habitual coffee consumption and renal impairment in Korean women, in consideration of diabetic status.

Methods

This study involved 2,673 women aged 35 to 84 years who had participated in the Fourth Korea National Health and Nutrition Examination Surveys, conducted in 2008. Habitual coffee consumption was classified into three categories: less than 1 cup per day, 1 cup per day, and 2 or more cups per day. Renal function impairment was defined as an estimated glomerular filtration rate less than 60 mL/min/1.73 m2 by the Modification of Diet in Renal Disease equation.

Results

The prevalence of diabetes and renal function impairment was higher in women who drank < 1 cup of coffee per day. Compared with drinking < 1 cup of coffee per day, the odds ratio (OR) for renal function impairment was significantly lower (OR, 0.59; 95% confidence interval [CI], 0.37 to 0.95; P = 0.03) in those who habitually drank ≥ 2 cups per day after adjusting for multiple confounding factors. When data were stratified according to the presence of diabetes, coffee consumption ≥ 2 cups of coffee per day showed an inverse association with renal function impairment in only diabetic women (OR, 0.14; 95% CI, 0.02 to 0.88; P = 0.04), compared with consumption < 1 cup of coffee per day.

Conclusion

In a representative sample of Korean women, coffee consumption was significantly associated with a decreased risk of renal impairment especially in middle and elderly-aged diabetic women.

Citations

Citations to this article as recorded by  
  • Coffee Intake, Plasma Caffeine Levels, and Kidney Function: Two-Sample Mendelian Randomization Among East Asian and European Ancestries
    Ryosuke Fujii, Masahiro Nakatochi, Fabiola Del Greco M.
    Kidney International Reports.2024; 9(4): 1083.     CrossRef
  • Association of habitual coffee consumption and kidney function: A prospective analysis in the Rotterdam Study
    Anniek C. van Westing, Carolina Ochoa-Rosales, Anna C. van der Burgh, Layal Chaker, Johanna M. Geleijnse, Ewout J. Hoorn, Trudy Voortman
    Clinical Nutrition.2023; 42(2): 83.     CrossRef
  • CYP1A2 Genetic Variation, Coffee Intake, and Kidney Dysfunction
    Sara Mahdavi, Paolo Palatini, Ahmed El-Sohemy
    JAMA Network Open.2023; 6(1): e2247868.     CrossRef
  • Adenosine receptors as emerging therapeutic targets for diabetic kidney disease
    Eun Seon Pak, Jin Joo Cha, Dae Ryong Cha, Keizo Kanasaki, Hunjoo Ha
    Kidney Research and Clinical Practice.2022; 41(Suppl 2): S74.     CrossRef
  • Effect of Coffee Consumption on Renal Outcome: A Systematic Review and Meta-Analysis of Clinical Studies
    Mehmet Kanbay, Dimitrie Siriopol, Sidar Copur, Laura Tapoi, Laura Benchea, Masanari Kuwabara, Patrick Rossignol, Alberto Ortiz, Adrian Covic, Baris Afsar
    Journal of Renal Nutrition.2021; 31(1): 5.     CrossRef
  • Association of self-reported moderate vegetable juice intake with small decline in kidney function in a five-year prospective study
    Ryosuke Fujii, Takaaki Kondo, Mineko Tsukamoto, Sayo Kawai, Tae Sasakabe, Mariko Naito, Yoko Kubo, Rieko Okada, Takashi Tamura, Asahi Hishida, Jun Ueyama, Yumi Hayashi, Joji Ohnishi, Nobuyuki Hamajima, Kenji Takeuchi, Kenji Wakai
    Nutrition.2021; 84: 111114.     CrossRef
  • Consumption of caffeinated beverages and kidney function decline in an elderly Mediterranean population with metabolic syndrome
    Andrés Díaz-López, Indira Paz-Graniel, Verónica Ruiz, Estefanía Toledo, Nerea Becerra-Tomás, Dolores Corella, Olga Castañer, J. Alfredo Martínez, Ángel M. Alonso-Gómez, Julia Wärnberg, Jesús Vioque, Dora Romaguera, José López-Miranda, Ramon Estruch, Franc
    Scientific Reports.2021;[Epub]     CrossRef
  • Metabolites Associated with Coffee Consumption and Incident Chronic Kidney Disease
    William J. He, Jingsha Chen, Alexander C. Razavi, Emily A. Hu, Morgan E. Grams, Bing Yu, Chirag R. Parikh, Eric Boerwinkle, Lydia Bazzano, Lu Qi, Tanika N. Kelly, Josef Coresh, Casey M. Rebholz
    Clinical Journal of the American Society of Nephrology.2021; 16(11): 1620.     CrossRef
  • Coffee Consumption and Kidney Function: A Mendelian Randomization Study
    Oliver J. Kennedy, Nicola Pirastu, Robin Poole, Jonathan A. Fallowfield, Peter C. Hayes, Eryk J. Grzeszkowiak, Maarten W. Taal, James F. Wilson, Julie Parkes, Paul J. Roderick
    American Journal of Kidney Diseases.2020; 75(5): 753.     CrossRef
  • Investigation of antioxidant and anti-inflammatory activities as well as the renal protective potential of green coffee extract in high fat-diet/streptozotocin-induced diabetes in male albino rats
    Ohoud D. AlAmri, Rasha S. Albeltagy, Ahmed M. A. Akabawy, Shahenda Mahgoub, Doaa M. Abdel-Mohsen, Ahmed E. Abdel Moneim, Hatem K. Amin
    Journal of Functional Foods.2020; 71: 103996.     CrossRef
  • A Healthy Beverage Score and Risk of Chronic Kidney Disease Progression, Incident Cardiovascular Disease, and All-Cause Mortality in the Chronic Renal Insufficiency Cohort
    Emily A Hu, Cheryl AM Anderson, Deidra C Crews, Katherine T Mills, Jiang He, Haochang Shou, Jonathon J Taliercio, Madhumita J Mohanty, Zeenat Bhat, Josef Coresh, Lawrence J Appel, Casey M Rebholz
    Current Developments in Nutrition.2020; 4(6): nzaa088.     CrossRef
  • Coffee Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study
    Emily A. Hu, Elizabeth Selvin, Morgan E. Grams, Lyn M. Steffen, Josef Coresh, Casey M. Rebholz
    American Journal of Kidney Diseases.2018; 72(2): 214.     CrossRef
  • Prevalence of kidney dysfunction in diabetes mellitus and associated risk factors among productive age Indonesian
    Laurentia Mihardja, Delima Delima, Roy G. A. Massie, Muhammad Karyana, Pringgodigdo Nugroho, Em Yunir
    Journal of Diabetes & Metabolic Disorders.2018; 17(1): 53.     CrossRef
  • Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis
    Mattias Carlström, Susanna C Larsson
    Nutrition Reviews.2018; 76(6): 395.     CrossRef
  • Consumption of Coffee but Not of Other Caffeine-Containing Beverages Reduces the Risk of End-Stage Renal Disease in the Singapore Chinese Health Study
    Quan-Lan Jasmine Lew, Tazeen Hasan Jafar, Aizhen Jin, Jian-Min Yuan, Woon-Puay Koh
    The Journal of Nutrition.2018; 148(8): 1315.     CrossRef
  • Nutrients, Nutraceuticals, and Xenobiotics Affecting Renal Health
    Carmela Cosola, Alice Sabatino, Ighli Di Bari, Enrico Fiaccadori, Loreto Gesualdo
    Nutrients.2018; 10(7): 808.     CrossRef
  • Association of coffee consumption and chronic kidney disease: A meta-analysis
    Karn Wijarnpreecha, Charat Thongprayoon, Natanong Thamcharoen, Panadeekarn Panjawatanan, Wisit Cheungpasitporn
    International Journal of Clinical Practice.2017; 71(1): e12919.     CrossRef
  • Coffee and kidney disease
    Oliver John Kennedy, Paul Roderick, Robin Poole, Julie Parkes
    International Journal of Clinical Practice.2017; 71(8): e12980.     CrossRef
  • Adenosine signaling in diabetes mellitus and associated cardiovascular and renal complications
    Maria Peleli, Mattias Carlstrom
    Molecular Aspects of Medicine.2017; 55: 62.     CrossRef
  • Glycemic Reaction of Glimepiride Combined with Popular Egyptian Antidiabetic Drinks of Fenugreek and Coffee in Diabetic Rats
    Mai Abd Al-Khalik Gharib
    Pakistan Journal of Nutrition.2016; 15(2): 194.     CrossRef
  • Caffeine intake enhances the benefits of sodium glucose transporter 2 inhibitor
    Yoshitaka Hashimoto, Muhei Tanaka, Masahiro Yamazaki, Koji Nakano, Emi Ushigome, Hiroshi Okada, Yohei Oda, Naoto Nakamura, Michiaki Fukui
    Diabetes/Metabolism Research and Reviews.2016; 32(7): 694.     CrossRef
  • Coffee and tea consumption in relation to estimated glomerular filtration rate: results from the population-based longitudinal Doetinchem Cohort Study
    Gerrie-Cor M Herber-Gast, Hanneke van Essen, WM Monique Verschuren, Coen DA Stehouwer, Ron T Gansevoort, Stephan JL Bakker, Annemieke MW Spijkerman
    The American Journal of Clinical Nutrition.2016; 103(5): 1370.     CrossRef
  • The Relationship between Mothers’ Attachment Levels, Types of Verbal Control, and Infants’ Language Development
    Hyo Jung Nam, Kyung Eun Jahng
    Korean Journal of Child Studies.2015; 36(4): 143.     CrossRef
  • 5,936 View
  • 38 Download
  • 23 Crossref
Non-alcoholic Fatty Liver Disease and Chronic Kidney Disease in Koreans Aged 50 Years or Older
Ah-Leum Ahn, Jae-Kyung Choi, Mi-Na Kim, Seun-Ah Kim, Eun-Jung Oh, Hyuk-Jung Kweon, Dong-Yung Cho
Korean J Fam Med 2013;34(3):199-205.   Published online May 24, 2013
DOI: https://doi.org/10.4082/kjfm.2013.34.3.199
Background

Non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) share common pathogenic mechanisms and many risk factors, and both are linked to an increased risk of cardiovascular diseases. The aim of this study was to assess the association between NAFLD and CKD according to the presence of hypertension and diabetes mellitus in Koreans aged 50 years or older.

Methods

A cross-sectional study of 1,706 subjects who received their routine health examination was conducted between May 2008 and April 2010 at Konkuk University medical center. Biochemical tests for liver and abdominal ultrasonography were performed. CKD was defined as either proteinuria or glomerular filtration rate ≤60 mL/min per 1.73 m2.

Results

Among the 1,706 subjects, There were 545 (31.9%) with non-alcoholic fatty liver disease and 424 (24.9%) with chronic kidney disease. In univariate logistic regression analysis, NAFLD was significantly associated with CKD (odds ratio [OR], 1.69; 95% confidence interval [CI], 1.34 to 2.12). In multivariate logistic regression analysis adjusted for age, sex, current smoking, abdominal obesity, aspartate aminotransferases, alanine aminotransferases, γ-glutamyltransferase, hypertension, diabetes mellitus, hypertriglyceridemia, and low high-density lipoprotein cholesterol, NAFLD was associated with CKD (adjusted OR, 1.68; 95% CI, 1.27 to 2.24). This relationship remained significant after classification according to the presence of hypertension or diabetes mellitus.

Conclusion

NAFLD diagnosed by ultrasonography was significantly associated with CKD in Koreans aged 50 years or older.

Citations

Citations to this article as recorded by  
  • Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis
    Marc Gurun, Paul Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F. Dillon, Christopher J. Byrne, Anna Di Sessa
    PLOS ONE.2024; 19(4): e0299507.     CrossRef
  • Impact of Kiwifruit Consumption on Cholesterol Metabolism in Rat Liver: A Gene Expression Analysis in Induced Hypercholesterolemia
    Abdolvahab Ebrahimpour Gorji, Anna Ciecierska, Hanna Leontowicz, Zahra Roudbari, Tomasz Sadkowski
    Nutrients.2024; 16(23): 3999.     CrossRef
  • Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease Cross Talk
    Jacob Nysather, Eda Kaya, Paul Manka, Prakash Gudsoorkar, Wing-Kin Syn
    Advances in Kidney Disease and Health.2023; 30(4): 315.     CrossRef
  • Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease
    Ziwen Tao, Yueyue Li, Baoquan Cheng, Tao Zhou, Yanjing Gao
    Journal of Clinical and Translational Hepatology.2022; 10(1): 164.     CrossRef
  • Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease
    Chan-Young Jung, Geun Woo Ryu, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
    Diabetologia.2022; 65(3): 518.     CrossRef
  • Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease
    Mehmet Kanbay, Mustafa C. Bulbul, Sidar Copur, Baris Afsar, Alan A. Sag, Dimitrie Siriopol, Masanari Kuwabara, Silvia Badarau, Adrian Covic, Alberto Ortiz
    Journal of Nephrology.2021; 34(3): 649.     CrossRef
  • Beneficial Effects of Tamarind Trypsin Inhibitor in Chitosan–Whey Protein Nanoparticles on Hepatic Injury Induced High Glycemic Index Diet: A Preclinical Study
    Ana J. F. C. Aguiar, Jaluza L. C. de Queiroz, Pedro P. A. Santos, Christina S. Camillo, Alexandre C. Serquiz, Izael S. Costa, Gerciane S. Oliveira, Ana F. T. Gomes, Lídia L. R. Matias, Rafael O. A. Costa, Thaís S. Passos, Ana H. A. Morais
    International Journal of Molecular Sciences.2021; 22(18): 9968.     CrossRef
  • Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
    Stefania Kiapidou, Christina Liava, Maria Kalogirou, Evangelos Akriviadis, Emmanouil Sinakos
    Annals of Hepatology.2020; 19(2): 134.     CrossRef
  • Association of nonalcoholic fatty liver and chronic kidney disease: An analysis of 37,825 cases from health checkup center in Taiwan
    Hao-Wen Liu, Jia-Sin Liu, Ko-Lin Kuo
    Tzu Chi Medical Journal.2020; 32(1): 65.     CrossRef
  • NAFLD as a driver of chronic kidney disease
    Christopher D. Byrne, Giovanni Targher
    Journal of Hepatology.2020; 72(4): 785.     CrossRef
  • Correlation Between Non-Alcoholic Fatty Liver and Chronic Kidney Disease
    Hasyim Kasim, St. Rabiul Zatalia, Haerani Rasyid, Syakib Bakri, Muhammad L. Parewangi, Fardah Akil, Arifin Seweng
    The Open Urology & Nephrology Journal.2020; 13(1): 1.     CrossRef
  • Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
    Andrew A. Li, Aijaz Ahmed, Donghee Kim
    Gut and Liver.2020; 14(2): 168.     CrossRef
  • Risk of Kidney Dysfunction IN Nafld
    Alessandro Mantovani, Chiara Zusi, Andrea Dalbeni, Giorgio Grani, Elena Buzzetti
    Current Pharmaceutical Design.2020; 26(10): 1045.     CrossRef
  • Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease
    Rajkumar Chinnadurai, James Ritchie, Darren Green, Philip A Kalra
    Nephrology Dialysis Transplantation.2019; 34(3): 449.     CrossRef
  • Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis
    Robert M. Wilechansky, Alison Pedley, Joseph M. Massaro, Udo Hoffmann, Emelia J. Benjamin, Michelle T. Long
    Liver International.2019; 39(8): 1535.     CrossRef
  • Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity‐matched cohort study
    Haesuk Park, Ghadeer K. Dawwas, Xinyue Liu, Mindie H. Nguyen
    Journal of Internal Medicine.2019; 286(6): 711.     CrossRef
  • Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
    Leon A Adams, Quentin M Anstee, Herbert Tilg, Giovanni Targher
    Gut.2017; 66(6): 1138.     CrossRef
  • Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease
    Giovanni Targher, Christopher D. Byrne
    Nature Reviews Nephrology.2017; 13(5): 297.     CrossRef
  • Nonalcoholic fatty liver disease - A multisystem disease?
    Ivana Mikolasevic, Sandra Milic, Tamara Turk Wensveen, Ivana Grgic, Ivan Jakopcic, Davor Stimac, Felix Wensveen, Lidija Orlic
    World Journal of Gastroenterology.2016; 22(43): 9488.     CrossRef
  • NAFLD: A multisystem disease
    Christopher D. Byrne, Giovanni Targher
    Journal of Hepatology.2015; 62(1): S47.     CrossRef
  • Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes
    Yongqiang Li, Shuangshuang Zhu, Bin Li, Xiaofei Shao, Xinyu Liu, Aiqun Liu, Bifang Wu, Ying Zhang, Honglei Wang, Xiaohong Wang, Kangping Deng, Qin Liu, Min Huang, Hongmei Liu, Harry Holthöfer, Hequn Zou
    International Urology and Nephrology.2014; 46(9): 1785.     CrossRef
  • Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension
    Ki-Chul Sung, Sarah H. Wild, Christopher D. Byrne
    Journal of Hepatology.2014; 60(5): 1040.     CrossRef
  • Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
    Giovanni Musso, Roberto Gambino, James H. Tabibian, Mattias Ekstedt, Stergios Kechagias, Masahide Hamaguchi, Rolf Hultcrantz, Hannes Hagström, Seung Kew Yoon, Phunchai Charatcharoenwitthaya, Jacob George, Francisco Barrera, Svanhildur Hafliðadóttir, Einar
    PLoS Medicine.2014; 11(7): e1001680.     CrossRef
  • CKD and Nonalcoholic Fatty Liver Disease
    Giovanni Targher, Michel B. Chonchol, Christopher D. Byrne
    American Journal of Kidney Diseases.2014; 64(4): 638.     CrossRef
  • 4,637 View
  • 38 Download
  • 24 Crossref
Glomerular Filtration Rate Difference between Renal Cyst Group and Control Group.
Eun Jin Bae, Ju Seong Park, Seong Ho Han, Young Jin Park, You Ri Kim, Ho Woo Kim, Ki Han Kim
Korean J Fam Med 2011;32(2):97-103.   Published online February 20, 2011
DOI: https://doi.org/10.4082/kjfm.2011.32.2.97
Background
The simple renal cyst is the most prevalent cystic deformation in adults and is most of them are incidentally found during medical examination. In this study, the clinical differences were compared between simple renal cyst and control groups diagnosed by abdominal ultrasonography during periodic medical examination.Methods: We randomly selected 2,277 persons who took medical examination in one general hospital health promotion center. Among them, analysis was conducted for 188 subjects with simple renal cyst and 188 subjects without renal cyst whose sex, age, and body mass index were matched. Renal cyst subjects were compared with control group to search for their relationship with hypertension, renal function and microscopic hematuria, past medical history, social history, results of other abdominal ultrasonography findings, urine test, and blood test. Results: Among 2,213 subjects, simple renal cyst was found in 188 subjects (8.5%). The subjects who had more than three simple renal cysts were significant older (P = 0.05) and the oldest age was 70's. Also, higher hypertension prevalence (P = 0.05), more microscopic hematuria, higher serum creatinine (P = 0.02), and lower glomerular filtration rate (P < 0.01) were observed in simple renal cyst group. Conclusion: It is needed to survey size, shape and change of simple renal cyst using abdominal ultrasonography as well as how its progression may be related to developing hypertension, decreased renal function and microscopic hematuria.

Citations

Citations to this article as recorded by  
  • Relationship of Simple Renal Cyst to Hypertension
    Su-Mi Kim, Tae-Heum Chung, Myoung-Soon Oh, Sung-Gul Kwon, Sung-Jin Bae
    Korean Journal of Family Medicine.2014; 35(5): 237.     CrossRef
  • 2,074 View
  • 15 Download
  • 1 Crossref
Metabolic Syndrome and the Risk for Chronic Kidney Disease among Korean Women.
Sun Kyung Chae, Jee Soo Lee, Jee Hyun Chun, Hye Soon Park
Korean J Fam Med 2009;30(2):98-105.   Published online February 10, 2009
DOI: https://doi.org/10.4082/kjfm.2009.30.2.98
Background
Metabolic syndrome (MetS), characterized by abdominal obesity, hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol, high blood pressure, and high fasting glucose level, is a common risk factor for cardiovascular disease and associated complication. We examined the relationshipbetween the metabolic syndrome and risk of chronic kidney disease (CKD) in Korean women. Methods: We used data from 10,170 women, aged 30-89 years, who had visited the health examination center at a tertiary care hospital in 2006. The data were studied cross-sectionally. MetS was identified using the modified criteria of the National Cholesterol Education Program Adult Treatment Panel Ⅲ (NCEP-ATPⅢ). CKD was defined as an estimated GFR< 60 ml/min per 1.73 m2. The multivariable-adjusted(adjustment for age, a high school education, body mass index (BMI),alcohol drinking, current and former smoking, previous coronary heart disease, menopause and physical inactivity) odds ratio of CKD (95% CI) associated with each component of the metabolic syndrome, was calculated using logistic regression models. Result: 1,039 participants developed MetS. The multivariable-adjusted odds ratios (OR) of CKD in participants with MetS, hypertriglyceridemia and high blood pressure compared with participants without those factors were 2.68 (95% CI, 1.77-4.06), 1.96 (95% CI, 1.34-2.88), 2.00(95% CI, 1.38-2.89). Compared with participants with no MetS traits, those with one, two, equal to or more than three traits of MetShad OR of CKD of 1.24 (95% CI, 0.75-2.06), 1.56 (95% CI, 0.89-2.75), 2.18 (95% CI, 1.21-3.93), respectively. Conclusion: We found that Korean women with MetS had an increased risk for developing CKD. Finally, earlier identification and management of MetS might improve patient health and prevent the progression of CKD.
  • 1,895 View
  • 11 Download
TOP